CES 2025: Soliddd presents its SolidddVision smart glasses for people with vision loss
Patented virtual reality smartglasses are the first true vision correction for people living with vision loss due to macular degeneration.
SolidddVisionTM smartglasses, the first true vision correction for people living with vision loss due to macular degeneration, make their CES 2025 debut in Venetian Expo, Eureka Park.
The smartglasses technology was developed by Soliddd Corp., a New York City-based optical and vision technology company focused on restoring and improving sight for the millions of consumers worldwide with macular degeneration and other low vision disorders.
Soliddd’s scientifically formulated and user-tested virtual reality smartglasses are lightweight and feel like normal eyeglasses. SolidddVision provides the first true vision correction—and, indeed, sight restoration—for those living with vision loss due to macular degeneration.
The smartglasses use Soliddd’s unique and proprietary lens arrays, which resemble a fly’s eye, to project multiple separate images to the areas of the retina that are not damaged. This allows the brain to naturally construct stereopsis (the making of a 3D image in the brain) and a single full-field image with good acuity that feels like normal, in-focus sight.
Follow us on: 
At CES, Soliddd is featuring the beta headset version of its technology. The images here show the design for the actual consumer product to be introduced following rigorous patient testing and marketplace introduction in 2025. SolidddVision requires no FDA approval.
Follow us on: 
Cutting Edge Technology and Global Patents
Soliddd’s invention is over a decade in the making, leveraging its extensive know-how in 3D technology, portfolio of 15 U.S. and additional foreign patents (plus more pending) and proprietary optics and software including computer vision AI technology.
SolidddVision smartglasses use unique optics and software to beam many separate, in-focus views in a parallel-ray light field to all areas of the retina. The brain's visual cortex automatically constructs a single, stereo, full-field image with good acuity from the multiple inputs to each eye. Even if some areas of the wearer's visual field is blocked or unfocused, the redundant visual information received in other areas of the retina combines, resulting in the wearer seeing a full-field, well-focused and bright image.
In this Caption: Soliddd's SolidddVision glasses allow people with macular degeneration to see the full normal visual field with good acuity by:
(1) using two forward-facing video cameras to capture the world
(2) two inward-facing video cameras simultaneously map the inside of the eye for accurate automatic universal fit and gaze tracking
(3) software instantly processes incoming video with gaze tracking input and proper angle of view adjustment for stereo vision, correction for chromatic and spherical aberration, and other issues, and sends over 100 distinct views to two inward-facing displays behind SolidddVision lenses
(4) the viewer's brain then automatically brings together the separate images to construct a single, full-field 3D, sharply focused image for each eye.
"Soliddd has invented the first true vision correction for macular degeneration. We can provide sight in areas of the visual field where patients otherwise see nothing," said Neal Weinstock, CEO and founder, Soliddd. "SolidddVision smartglasses are lightweight and easily integrated into daily life. Our team is mission-driven to help restore and improve sight to the millions of consumers worldwide with vision loss caused by macular degeneration."
The SolidddVision smartglasses breakthrough has been supported by physicians and scientists including numerous board certified ophthalmologists, retinologists and optometrists.
"I was able to observe numerous demonstrations of SolidddVision with patients affected by numerous ocular disease conditions including age-related macular degeneration, glaucoma, diabetic retinopathy and stroke," said Georgia K. Crozier OD, MS and Director of the Moore Eye Institute Vision Rehabilitation Center in Pennsylvania.
"These patients responded positively to the improved visual acuity and all believed it would help them in their daily activities. The enhancement of their reading vision and the ease of use was remarkable. This technology will be groundbreaking."